ABSTRACT The purpose of these experiments was to determine the frequency dependence of the effects of amiodarone and its active desethyl metabolite on slow-channel tissues. Intravenous amiodarone and desethylamiodarone (10 or 25 mg/kg) increased atrioventricular conduction time (AVCT) and refractory period (AVERP) trophysiologic actions was increased by studies showing it to be a sodium-channel blocker.5 Amiodarone's beneficial effects against supraventricular arrhythmias are predominantly due to a depressant effect on the atnroventricular (AV) node.' This action, along with the antihypertensive, antianginal, sinus node-slowing, and occasional negative inotropic effects of amiodarone have been attributed to a noncompetitive adrenergic blocking action of the drug.6 7 The electrophysiologic effects of intravenous amiodarone are known to differ from the effects of long-term oral amiodarone therapy.8 Short-term intravenous amiodarone administration alters sinus and AV node properties with little, if any, effect on fast-channel tissues,8' 9 whereas long-term oral amiodarone importantly increases refractory period and slows conduction in fast-channel tissues.' We have shown that accumulation of amiodarone's desethyl metabolite is responsible for much of this long-term effect on fast-CIRCULATION 442
trophysiologic actions was increased by studies showing it to be a sodium-channel blocker. 5 Amiodarone's beneficial effects against supraventricular arrhythmias are predominantly due to a depressant effect on the atnroventricular (AV) node.' This action, along with the antihypertensive, antianginal, sinus node-slowing, and occasional negative inotropic effects of amiodarone have been attributed to a noncompetitive adrenergic blocking action of the drug.6 7 The electrophysiologic effects of intravenous amiodarone are known to differ from the effects of long-term oral amiodarone therapy.8 Short-term intravenous amiodarone administration alters sinus and AV node properties with little, if any, effect on fast-channel tissues,8' 9 whereas long-term oral amiodarone importantly increases refractory period and slows conduction in fast-channel tissues. ' We have shown that accumulation of amiodarone's desethyl metabolite is responsible for much of this long-term effect on fast-CIRCULATION LABORATORY INVESTIGATION-ELECTROPHYSIOLOGY channel tissues.'0 In the course of the latter experiments, we found that both desethylamiodarone and amiodarone produced frequency-dependent slowing of AV node conduction. These use-dependent effects on AV conduction were similar to changes we had previously observed using a similar experimental preparation to study the actions of calcium-channel blockers. " This led us to hypothesize that amiodarone and its metabolite produce interval-related depression of calcium channel-dependent tissues. The present experiments were designed to characterize the time dependence of the depressant effects of amiodarone and desethylamiodarone on AV conduction in vivo and on slow-channel action potentials in vitro. Preliminary results of this work have been presented in abstract forn. 12 
Methods

General methods
Experiments in vivo. Mongrel dogs of either sex were anesthetized with morphine (2 mg/kg im) and a-chloralose (100 mg/kg iv). Catheters were inserted into both femoral arteries, and both femoral veins were kept patent with heparinized saline (0.9%). Dogs were ventilated via an endotracheal tube at a rate of 10/min with a tidal volume obtained from a nomogram relating body weight to minute ventilation. Arterial blood gases were measured to ensure adequate oxygenation (Sao2 . 90%) and physiologic pH (7. 38 to 7.45). A right thoracotomy was performed and two bipolar Teflon-coated stainless-steel electrodes were inserted into the right atrial appendage for recording and stimulation. A Statham P23 ID transducer (Statham Medical Instruments, Los Angeles), electrophysiologic amplifiers, and a paper recorder (Siemens Mingograf 80 recorder) were used to record blood pressure, electrocardiographic leads II and aVR, a right atrial electrogram, and stimulus artifacts. Stimulation was applied with 4 msec square-wave pulses at twice diastolic threshold current controlled by a programmable stimulator (Caltronics, Inc.).
Autonomic blockade was achieved by a previously developed regimen." This consisted of a single 1 mg iv dose of atropine and an initial dose of 0.3 mg/kg iv propranolol followed by 0.45 mg/kg/hr propranolol as a continuous intravenous infusion.
Experiments in vitro. Mongrel dogs were anesthetized with pentobarbital (30 mg/kg iv) and their hearts were removed via a right thoracotomy. Ventricular fibrillation was induced electrically to facilitate tissue dissection, and free-running false tendons were removed along with subjacent ventricular muscle and pinned to the Sylgard-covered bottom of a Lucite tissue bath. The false tendons were initially superfused with Tyrode's solution containing (in mM): Nat, 141; HCO3-, 22; dextrose, 10; K', 4; Mg2, 0.5; H2P04 0.9;Ca2, 2.7;andCl 128.The solution was aerated with 95% 02/5% C02, resulting in a mean pH of 7.3 in the tissue bath, and the temperature in the bath was maintained at 360 ± 0.20 C by a feedback-controlled proportional power supply. The preparation was stimulated at a selected frequency by 2 msec twice diastolic threshold, square wave pulses delivered through bipolar platinum electrodes. A stimulus isolator controlled by a programmable stimulator (Bloom Associates, Flying Hills, PA) was used as a current source. The frequency dependence of AV conduction and refractoriness were determined by pacing the atrium at a variety of basic cycle lengths between 300 and 1000 msec. After at least 2 min of continuous stimulation at each cycle length, AVCT was measured and the effective refractory period of the AV conducting system (AVERP) was determined by the extrastimulus technique. The AVERP was defined as the longest S1S2 interval failing to produce a ventricular response during atrial pacing. When atrial refractoriness was limiting, the atrial ERP was taken as an upper estimate of the AV nodal ERP value. The interval dependence of AV conduction was determined by pacing the atrium at a rate just below the Wenckebach frequency and introducing a pause of varying duration after every 20 basic stimuli.
The above measurements were obtained under control conditions and repeated 60 min after the administration of amiodarone or desethylamiodarone. Doses of 10 or 25 mg/kg of either agent were administered over 20 min, dissolved in 2 ml of 50% ethanol. Only one dose of one agent was studied in each dog. This vehicle for amiodarone administration has previously been shown to have no effect on the variables measured in these experiments.'5 Amiodarone and desethylamiodarone were obtained as the purified hydrocholoride salts from Sanofi Research, Inc., and kindly supplied by Ayerst Laboratories, Montreal, Canada.
Experiments in vitro. After slow-channel action potentials had been produced as described above, action potential characteristics were followed for at least 30 min to ensure their stability. 160± 24 238 ± 13D A10 = effect of 10 mg/kg amiodarone (n = 8 dogs); A25 = 25 mg/kg amiodarone (n = 5 dogs); D10 = 10 mg/kg desethylamiodarone (n = 6 dogs); D25 = 25 mg/kg desethylamiodarone (n = 5 dogs).
AValues shown are AVCT or refractory periods (msec) before and after drug administration.
Blnsufficient data for presentation. AChanges in AVCT were fitted to a relationship of the form AAVCT = Ae C-Ll'f + Be -Clts, where AAVCT = difference between AVCT at coupling interval (CI) and AVCT at the longest pause obtainable. For control conditions, a monoexponential relationship was observed and B was set to zero.
Interval dependence of changes in Vmax of slow-channel action potentials before and after amiodarone superfusion in vitro: Tf amiodarone did not produce any change from control in the relationship between Vmax and premature coupling interval.
Discussion
We have shown that the effects of amiodarone and its active desethyl metabolite on AV nodal properties are frequency dependent. At a heart rate of 60 beats/ min, these agents increased AV conduction time and AVERP by an average of 25% and 31%, respectively (pooled data from all dogs). In contrast, at an atrial rate of 150 beats/min, AVCT was increased by a mean of 62% and AVERP by 85%. The magnitude of changes in AV nodal properties that we observed at slow heart rates is similar to changes measured by other investigators after administration of amiodarone in man. 18' 9 No comparable clinical studies regarding amiodarone's effect on the AV node at rapid heart rates are available. The frequency dependence of amiodarone's actions on AV nodal conduction should be valuable in selectively suppressing reentrant tachycardias involving the AV node and reducing the ventricular response rate in atrial fibrillation.
The mechanisms underlying amiodarone's frequency-dependent effect on AV conduction can, to large measure, be deduced from these observations. Under Calcium channel-blocking properties of amiodarone could account for a variety of important clinical observations. The antianginal effects of amiodarone are consistent with calcium-channel blockade, as are the occasional adverse effects of hypotension and left ventricular dysfunction.28 Changes in sinoatrial and AV nodal function are also attributable to amiodarone's calcium channel-blocking properties and account for beneficial effects against reentrant supraventricular tachycardias and atrial fibrillation29 as well as for the adverse consequences of sinus node dysfunction and AV block." 28 Although amiodarone is perhaps best known for its ability to prolong the QT interval, it has rarely been implicated in the initiation of torsades de pointes arrhythmias associated with the long QT syndrome. Early afterdepolarizations are currently believed to be central in the pathogenesis of the ventricular tachyarrhythmias in the long QT syndrome.30' 31 Recent work suggests that early afterdepolarizations are caused by a slow channel-dependent mechanism,32 implying that the rarity of amiodaroneinduced long QT syndromes may be a result of amiodarone's ability to depress the slow current responsible for arrhythmogenesis. Amiodarone has in fact been shown to depress depolarization-induced automatic- The time course of recovery of slow-channel properties from amiodarone blockade is also significant. It is substantially more rapid than the recovery from blockade by verapamil and diltiazem,ii and considerable unbinding of amiodarone and its metabolite would be anticipated before the next activation at normal heart rates. This could account for the rarity of AV block and left ventricular dysfunction as adverse effects of amidarone., 2, 27 On the other hand, at the rapid activation rates characteristic of atrial fibrillation and AV reentrant tachycardias, the diastolic time available for drug unbinding between AV nodal activations is substantially less than amiodarone's recovery time constant. Consequently, block would be expected to accumulate and AV nodal conduction would be depressed. The ideal recovery time constant to allow for depression of tachycardias with little effect during sinus rhythm is in the range of 0.5 to 1 sec. In this study, amiodarone's effects on slow-channel properties were found to recover with a time constant in this theoretically optimal range.
